Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Prevention of IL-2 Induced Depression in Melanoma
NCT00352885Phase 4Completed
- Sponsor
- Emory University
- Start
- Oct 2006
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Emory University. Started Oct 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00352885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352885.